Skip to main navigation Skip to search Skip to main content

Bronchoplastic resection for non-small-cell lung cancer

  • C. Müller
  • , C. Schinkel
  • , H. Hoffmann
  • , H. Dienemann
  • , F. W. Schildberg
  • Ludwig-Maximilians-Universität München

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

During the past 12 years, among 1478 operations for non-small-cell lung cancer (NSCLC), 102 (6.9%) bronchosplastic resections were performed. There were 74 lobectomies, 19 bilobectomies, and 9 pneumonectomies done by means of 72 sleeve-, 28 wedge resections, and 2 resections of the tracheal bifurcation. Atelectasis was observed in 6%, whereas anastomotic dehiscence occurred in 4%. Local complete resection was achieved in 81%. The 30-day mortality amounted to 4%. Our results demonstrate that bronchoplastic procedures represent a safe therapeutic option in the operative treatment of central NSCLC.

Original languageEnglish
Pages (from-to)248-251
Number of pages4
JournalThoracic and Cardiovascular Surgeon
Volume44
Issue number5
DOIs
StatePublished - Oct 1996
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • NSCLC
  • bronchoplastic resection

Fingerprint

Dive into the research topics of 'Bronchoplastic resection for non-small-cell lung cancer'. Together they form a unique fingerprint.

Cite this